Our new oncology patent WO2022180080 was approved and is already available in the WIPO database. The patent protects a new generation of antitumor agents with…
Cancer
A study led by First Health Pharmaceuticals B.V. (FHPBV) and the Italian Institute of oncological research and prevention (ISPRO), together with the University of Siena…
Besides our Research and Development in The Netherlands, First Health Pharmaceuticals has important collaborations worldwide, especially in countries such as India and Italy. Recently we…
First Health Pharmaceuticals will participate in the workshop organized by Oncode Institute dedicated to glioblastoma. The workshop will be held on October 16th 2019, in…
The Breast Cancer Awareness Month wants to raise awareness about the disease among women across the world every October. BREAST CANCER STATISTICS The female breast…
First Heath Pharmaceuticals is thrilled to announce the participation at the European Society for Clinical Cell Analysis, ESCCA 2019, of one of its major collaboration…
First Health Pharmaceuticals is thrilled to announce its latest collaboration on cancer research with an Oncode Institute-affiliate. Oncode is an independent Dutch research institute established…
Breast cancer awareness month is a worldwide annual campaign that involves several organisations all around the world to help raise awareness about breast cancer through…
First Health Pharmaceuticals and First Health United Foundation are going to participate at AIDS2018, the 22nd International AIDS Conference on HIV and AIDS, which will take…
The latest results of a wide range of cell culture assays of some of our compounds against triple negative metastatic breast cancer, metastatic (smokers) lung…